10MD attracts capital

10MD has raised capital in a funding round from selected private investors. The funding will primarily be used to scale up production capacity of TeXray.

Ten Medical Design AB (10MD) is a medical technology company committed to providing innovative products to healthcare professionals. In February 2017, the developed radiation protection material NAFT fulfilled technical requirements and passed conformity tests in radiation protection at the test institute Physikalisch-Technische Bundesanstalt in Germany.

10MD has raised capital in a funding round from selected private investors. The issue of shares was closed in June 30 and enables 10MD to scale up production of NAFT.

"Increasing production capacity of TeXray is an important step towards delivering on market demands", says Mr Fredrik Gellerstedt, CEO of 10MD.

* HeadPeace and TeXray are trademarks of Ten Medical Design AB.

Leave a comment

Please note, comments must be approved before they are published